STATE OF NEW YORK
________________________________________________________________________
7338
2023-2024 Regular Sessions
IN ASSEMBLY
May 17, 2023
___________
Introduced by M. of A. PAULIN -- read once and referred to the Committee
on Health
AN ACT to amend the public health law, in relation to newborn screening
for glucose-6-phosphate dehydrogenase deficiency
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Paragraph (j) of subdivision 1 of section 2500-a of the
2 public health law, as amended by chapter 70 of the laws of 2022, is
3 amended to read as follows:
4 (j) Glucose-6-phosphate dehydrogenase deficiency [using a quantitative
5 enzymatic test or other diagnostic test in cases where: the newborn
6 infant presents with hemolytic anemia, hemolytic jaundice, or early-on-
7 set increasing neonatal jaundice, that is, jaundice (bilirubin level
8 greater than fortieth percentile for age in hours) persisting beyond the
9 day of birth through the week after birth; the newborn infant has been
10 admitted to the hospital for jaundice following birth; or the biological
11 parent of the newborn infant indicates a family, racial, or ethnic risk
12 of glucose-6-phosphate dehydrogenase deficiency, including having
13 significant African, Asian, Mediterranean, or Middle Eastern ancestry].
14 § 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD10869-02-3
